Skip to main content
news
REUTERS/Tingshu Wang

Cooley, CYL & Partners and DeHeng Law Offices have advised China’s Asymchem Laboratories on its HK$6.85 billion ($878 million) secondary listing in Hong Kong, with Latham & Watkins and JunHe representing the joint sponsors.

This is believed to be the biggest healthcare IPO in Hong Kong this year. The company has been listed on the Shenzhen Stock Exchange since 2016.

Asymchem is a Chinese contract development manufacturing organisation (CDMO) serving the global pharmaceutical industry. According to Frost & Sullivan, it is the world’s fifth-largest drug substance CDMO by revenue, and the largest China-based commercial stage chemical drug CDMO.

The Cooley team was led by partners Yiming Liu and Michael Yu.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com.

Related Articles

Deals

CC, DFDL, Bakers, HBS act on $550 mln Cambodia microfinance deal

by Asian Legal Business《亚洲法律杂志》 |

Magic Circle law firm Clifford Chance and DFDL have advised a consortium of investors on the $550 million sale of Cambodian microfinance institution Amret to Taiwan's Bank SinoPac, which was represented by Baker McKenzie Taiwan and local firm HBS Law.

Deals

A&O Shearman guides $1.2 bln Malaysian data centre deal

by Nimitt Dixit |

Global law firm A&O Shearman has advised Malaysian real estate firm Sime Darby Property (SDP) on a $1.2 billion agreement to develop and lease a data centre campus in Malaysia with Google-backed Pearl Computing Malaysia.

Deals

CC, Milbank, Rahmat Lim, Zul Rafique advise on $900 mln M’sia data centre financing

by Asian Legal Business《亚洲法律杂志》 |

Clifford Chance and Rahmat Lim & Partners have represented data centre developer Yondr Group in securing over $900 million in project financing for its hyperscale data centre in Johor, Malaysia. Milbank advised the finance partie